Pharmacology

Our scientists can perform studies to demonstrate the clinical utility of drug candidates and preclinical studies to support regulatory approval. 

Scottish Biomedical provides a comprehensive service for the evaluation of the efficacy of drug candidates in a range of pharmacologically-relevant disease models (cell-based, tissue based and organ bath), monitoring a range of biological parameters and relevant biomarkers (including the use of human tissues).

We also perform in vitro studies to determine and optimize the ADME profile of lead compounds (metabolic and cytochrome stability, cyto-and genotoxicity, oral absorption and BBB penetration).